Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Trans R Soc Trop Med Hyg ; 110(12): 690-695, 2016 12 01.
Artigo em Inglês | MEDLINE | ID: mdl-28938053

RESUMO

Background: Among the 216 districts in Ghana, 98 were declared endemic for lymphatic filariasis in 1999 after mapping. Pursuing the goal of elimination, WHO recommends annual treatment using mass drugs administration (MDA) for at least 5 years. MDA was started in the country in 2001 and reached national coverage in 2006. By 2014, 69 districts had 'stopped-MDA' (after passing the transmission assessment survey) while 29 others remained with persistent microfilaraemia (mf) prevalence (≥1%) despite more than 11 years of MDA and were classified as 'hotspots'. Methods: An ecological study was carried out to compare baseline mf prevalence and anti-microfilaria interventions between hotspot and stopped-MDA districts. Results: Baseline mf prevalence was significantly higher in hotspots than stopped-MDA districts (p<0.001). After three years of MDA, there was a significant decrease in mf prevalence in hotspot districts, but it was still higher than in stopped-MDA districts. The number of MDA rounds was slightly higher in hotspot districts (p<0.001), but there were no differences in coverage of MDA or long-lasting-insecticide-treated nets. Conclusions: The main difference in hotspots and stopped-MDA districts was a high baseline mf prevalence. This finding indicates that the recommended 5-6 rounds annual treatment may not achieve interruption of transmission.


Assuntos
Filariose Linfática/tratamento farmacológico , Filariose Linfática/epidemiologia , Doenças Endêmicas/prevenção & controle , Doenças Endêmicas/estatística & dados numéricos , Filaricidas/administração & dosagem , Administração Massiva de Medicamentos/estatística & dados numéricos , Animais , Antígenos de Helmintos/imunologia , Transmissão de Doença Infecciosa/prevenção & controle , Esquema de Medicação , Filariose Linfática/prevenção & controle , Filariose Linfática/transmissão , Filaricidas/farmacologia , Filaricidas/uso terapêutico , Gana/epidemiologia , Pesquisa sobre Serviços de Saúde , Humanos , Microfilárias/imunologia , Prevalência , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA